๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome

โœ Scribed by Feng Gao; J. Philip Miller; Chengjie Xiong; Julia A. Beiser; Mae Gordon; The Ocular Hypertension Treatment Study (OHTS) Group

Publisher
Springer
Year
2010
Tongue
English
Weight
660 KB
Volume
20
Category
Article
ISSN
1613-981X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A new definition of pharmaceutical quali
A new definition of pharmaceutical quality: Assembly of a risk simulation platform to investigate the impact of manufacturing/product variability on clinical performance
โœ Steven M. Short; Robert P. Cogdill; Frank D'Amico; James K. Drennen III; Carl A. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 477 KB ๐Ÿ‘ 1 views

The absence of a unanimous, industry-specific definition of quality is, to a certain degree, impeding the progress of ongoing efforts to "modernize" the pharmaceutical industry. This work was predicated on requests by Dr. Woodcock (FDA) to re-define pharmaceutical quality in terms of risk by linking